Molecular Hydrogen in Cancer Research: Insights from Scientific Studies

Research into molecular hydrogen (H₂) has increased significantly in recent years. An excerpt from the following scientific studies demonstrates that hydrogen may serve as a promising complementary approach in cancer prevention and therapy. The body receives support through its antioxidant, anti-inflammatory, and immunomodulatory effects.

This review article summarizes numerous experimental and clinical studies. The authors conclude that molecular hydrogen:

• reduces oxidative stress,
• inhibits chronic inflammation,
• improves immune system function,
• can render tumor cells more sensitive to chemotherapy and immunotherapy,
• and could reduce the side effects of conventional cancer treatments.

The review article in the abstract, as well as the cited studies, identify, among other things:

In patients with advanced colorectal and lung cancer, it has been reported that hydrogen gas was able to partially reactivate exhausted CD8⁺ T cells. This was associated with an improved immune response and, in some studies, with prolonged survival.

This review article describes in detail the biological mechanisms through which hydrogen could influence cancer processes. Hydrogen can:

• selectively neutralize particularly aggressive free radicals,
• protect mitochondria,
• regulate cellular signaling,
• reduce DNA damage,
• attenuate chronic inflammatory responses,
• influence cancer development at multiple levels.

The study in the abstract, as well as the cited studies, identify, among other things:

Hydrogen appears to protect healthy cells from oxidative damage without significantly impairing the desired effects of chemotherapy or radiation. In some models, an enhancement of tumor inhibition was even observed.

This mechanism is particularly relevant for:

• Breast cancer
• Colorectal cancer
• Difficult-to-treat solid tumors with an immunosuppressive tumor microenvironment

Molecular hydrogen is the smallest molecule in the universe. As a result, it can rapidly distribute throughout the body and even penetrate cells and mitochondria. Potential benefits include:

1. Protection against cellular stress
   Hydrogen neutralizes particularly aggressive free radicals that can damage cells and DNA.
2. Anti-inflammatory effects
   Chronic inflammation promotes tumor growth. Hydrogen can attenuate inflammatory signaling pathways.
3. Immune system support
   Hydrogen can revitalize exhausted immune cells, thereby strengthening the body’s natural defenses against tumors.
4. Improvement of the tumor microenvironment
   Tumors create an environment that blocks immune cells. Hydrogen can make this environment less hospitable to tumors.
5. Potential reduction of therapy side effects
   Studies suggest that hydrogen may reduce fatigue, inflammation, and oxidative stress during chemotherapy or radiation therapy.
6. Potential support for chemo-, radiation, and immunotherapy
   In experimental models, enhanced efficacy of existing cancer therapies has been observed.

Molecular hydrogen can be introduced into the body primarily via two routes:

• Hydrogen-rich drinking water

• Hydrogen inhalation

Since H₂ is a neutral and very small molecule, it is rapidly absorbed and distributed throughout the lungs, blood, and tissues. It even penetrates physiological barriers – a characteristic that is advantageous in this context. When consuming hydrogen-rich drinking water – provided a high saturation of H₂ has been achieved in the water – a relatively large quantity of hydrogen is delivered to the body. However, since daily water intake is limited to just a few liters, one quickly reaches the upper limits of the absorbable quantity. Inhalation is therefore a more effective method, as it allows for the intake of hydrogen – or a hydrogen/oxygen mixture – over periods lasting up to several hours. The optimal approach involves combining both methods.

In cancer research, not only pure molecular hydrogen (H₂) but also the inhalation of a hydrogen-oxygen mixture (HHO) has been investigated. In clinical studies, a gas mixture was frequently employed. This 2:1 ratio typically results from the electrolysis of water. The typical composition of the inhalation gas is:

• 66,7 % hydrogen (H₂)
• 33,3 % oxygen (O₂)

This 2:1 ratio is naturally occurring and is known from so-called Brown’s gas. The review article with PubMed ID 38555538 describes clinical studies in which patients with advanced cancer inhaled a hydrogen-oxygen mixture. Among other findings, the following were observed:

• Improved quality of life,Reduction in fatigue,
• Enhanced immune function,
• In some cases, prolonged progression-free and overall survival.

The study by Akagi et al., cited in the review article, examined patients with advanced colorectal cancer and other solid tumors who inhaled a 66.7% H₂ / 33.3% O₂ mixture. The results demonstrated a reactivation of exhausted T-cells and a potential prolongation of survival time. Several cancer studies – such as those found at pmc.ncbi.nlm.nih.gov/articles/PMC6779007/ and pmc.ncbi.nlm.nih.gov/articles/PMC10152878/ – have specifically investigated the inhalation of a hydrogen-oxygen mixture (66.7% H₂ and 33.3% O₂). The findings suggest that this method of administration may:

• Support the immune system,
• Reduce therapy-related burdens,
• Improve quality of life,
• And potentially exert a positive influence on the course of the disease.

The primary therapeutic effect is attributed to molecular hydrogen, while the oxygen serves primarily to provide practical and physiological support.

Important Notice
BestElements is a member of the MHI. Current research is promising; however, hydrogen is not currently recognized as a standalone cancer therapy. The results presented are derived from clinical studies, as well as cell and animal models. Further randomized human trials are required to more conclusively assess its benefits and optimal application. Please refer to the disclaimer located at the bottom of every page.